World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
33982
World Ranking
10057
National Ranking
5177

Charles E. Myers publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Charles E. Myers sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 245 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Charles E. Myers D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Charles E. Myers sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 1992 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 1942 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Charles E. Myers is affiliated with the University of Virginia in the United States. Their research intersects several areas within psychology and medicine, with particular focus on clinical psychology, pulmonary and respiratory medicine, genetics, applied psychology, and general health professions.

Their scholarly contributions often explore topics related to human-animal interaction studies, behavioral health and interventions, health policy implementation science, child therapy and development, family and disability support research, parental involvement in education, as well as prostate cancer treatment and research.

Recent papers authored or coauthored by Myers include:

  • "The Effectiveness of Equine-Assisted Mental Health Interventions for Youth: A Meta-Analysis of Controlled Studies" (2023) published in Adolescent Research Review
  • "Successful strategies for parent engagement in play therapy: Voices through humanistic approaches." (2023) published in International Journal of Play Therapy
  • "Impact of Dutasteride on PSA Kinetics and Time to Progression in Men with PSA-only Recurrent Prostate Cancer" (2021) published in bioRxiv (Cold Spring Harbor Laboratory)
  • "Equine-Assisted Learning for At-Risk Youth: An Archival Study" (2025) published in HETI Journal International Research and Practice

Frequent co-authors in Myers' research work include:

  • Sarah Fuller-Lovins
  • Yasuko Kanamori
  • Jeffrey H. D. Cornelius-White
  • Mi-Hee Jeon
  • Michelle S McCarthy

Their publications have appeared in venues such as Adolescent Research Review, International Journal of Play Therapy, bioRxiv (Cold Spring Harbor Laboratory), and HETI Journal International Research and Practice.

Charles E. Myers has been recognized as a Fellow of the American Association for the Advancement of Science (AAAS), receiving this distinction in the years 1992 and 1942.

Best Publications

  • Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.

    L Whitesell;E G Mimnaugh;B De Costa;C E Myers

  • Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response

    Charles E. Myers;William P. McGuire;Robert H. Liss;Ina Ifrim

  • Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

    Glenn J. Bubley;Michael Carducci;William Dahut;Nancy Dawson

  • The anthracycline antineoplastic drugs.

    Robert C. Young;Robert F. Ozols;Charles E. Myers

  • ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

    Robert Yarchoan;Kent J. Weinhold;H. Kim Lyerly;Edward Gelmann

  • Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen Metabolites: ALTERATIONS PRODUCED BY DOXORUBICIN

    James H. Doroshow;Gershon Y. Locker;C. E. Myers

  • Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells.

    G Batist;A Tulpule;B K Sinha;A G Katki

  • Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer

    Dedrick Rl;Myers Ce;Bungay Pm;DeVita Vt

  • Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells

    Jagadananda Ghosh;Charles E. Myers

  • PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)

    Robert Yarchoan;Rose V. Thomas;Jean Pierre Allain;Nanette Mcatee

  • Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis

    Adi F. Gazdar;Herbert K. Oie;Cedric H. Shackleton;T. R. Chen

  • Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases.

    Raymond W Klecker;Jerry M Collins;Robert Yarchoan;Rose Thomas

  • Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides.

    Robert Yarchoan;Hiroaki Mitsuya;Charles E. Myers;Samuel Broder

  • Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer

    Alain Thibault;Dvorit Samid;Dvorit Samid;Anne C. Tompkins;William D. Figg

  • Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine.

    Robert Yarchoan;Robert Yarchoan;Pim Brouwers;Pim Brouwers;A. Robert Spitzer;A. Robert Spitzer;Jordan Grafman;Jordan Grafman;Jordan Grafman

  • Expression of Anionic Glutathione-S-transferase and P-Glycoprotein Genes in Human Tissues and Tumors

    Jeffrey A. Moscow;Craig R. Fairchild;Mary Jane Madden;David T. Ransom

  • Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275

    Gurmeet Kaur;Maryalice Stetler-Stevenson;Sandra Sebers;Peter Worland

  • Suramin: an anticancer drug with a unique mechanism of action.

    C A Stein;R V LaRocca;R Thomas;N McAtee

  • Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats

    Kenneth H. Cowan;Gerald Batist;Anil Tulpule;Birandra K. Sinha

  • Plasma Pharmacokinetics of Adriamycin and Adriamycinol: Implications for the Design of in Vitro Experiments and Treatment Protocols

    Raymond F. Greene;Jerry M. Collins;Jean F. Jenkins;James L. Speyer

Frequent Co-Authors

Bruce A. Chabner
Bruce A. Chabner Harvard University
Birandra K. Sinha
Birandra K. Sinha National Institutes of Health
Jerry M. Collins
Jerry M. Collins National Institutes of Health
James H. Doroshow
James H. Doroshow National Institutes of Health
Kenneth H. Cowan
Kenneth H. Cowan University of Nebraska Medical Center
Robert C. Young
Robert C. Young Cornell University
William D. Figg
William D. Figg National Institutes of Health
Samuel Broder
Samuel Broder Precision BioSciences
Robert Yarchoan
Robert Yarchoan National Institutes of Health
Robert F. Ozols
Robert F. Ozols Fox Chase Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering alternative pathways to a medical career? Many students opt for related online degrees that offer quicker entry into healthcare or administrative roles. For instance, online direct entry msn programs for non-nurses are designed for individuals with non-nursing backgrounds who want to fast-track into advanced practice nursing.

If you’re interested in nursing but concerned about competitiveness, you might explore easy nursing programs to get into. These schools generally have higher acceptance rates, making it easier to start your nursing journey.

For those seeking a non-clinical route in healthcare, becoming a medical biller or coder is a popular choice. There are highly regarded medical billing and coding online schools that offer flexibility and the option to apply for financial aid.

Finally, if entrance exams feel like a barrier, consider nursing tracks like the lpn program no entrance exam options, which do not require TEAS or HESI testing for admission.

Best Scientists Citing Charles E. Myers

Trending Scientists

Recently Published Articles